Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of ...

MyOme, a leader in clinical whole-genome analysis and integrated risk modeling, today announced research showing that integrating polygenic scores with clinical risk factors produces more precise and ...

Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic ...

New polygenic risk scores can more accurately predict obesity, type 2 diabetes, and downstream complications such as heart attack and stroke.

Biologically enriched MetPRS has the potential to add an extra layer of information to metabolic disease prediction and management approaches.

Cardiovascular disease ("CVD") is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD. CVD accounts for one in every three deaths in the US, or more than ...

Genetic variants associated with mental disorders do not have a significant influence on methylphenidate response in ADHD cohorts.

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...